{"status":"OK","data":{"id":2970154,"identifier":"DVN/I2OKAG","persistentUrl":"https://doi.org/10.7910/DVN/I2OKAG","protocol":"doi","authority":"10.7910","publisher":"Harvard Dataverse","publicationDate":"2017-02-15","storageIdentifier":"s3://dvn-cloud:10.7910/DVN/I2OKAG","latestVersion":{"id":97096,"storageIdentifier":"s3://dvn-cloud:10.7910/DVN/I2OKAG","versionNumber":1,"versionMinorNumber":0,"versionState":"RELEASED","productionDate":"Production Date","lastUpdateTime":"2017-02-15T10:42:35Z","releaseTime":"2017-02-15T10:42:35Z","createTime":"2017-01-12T02:18:10Z","license":"CC0","termsOfUse":"CC0 Waiver","metadataBlocks":{"citation":{"displayName":"Citation Metadata","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"Emmanuelle Charpentier CRISPR Patent Licenses and Press Releases"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Sherkow, Jacob"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"New York Law School"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Sherkow, Jacob"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"New York Law School"},"datasetContactEmail":{"typeName":"datasetContactEmail","multiple":false,"typeClass":"primitive","value":"jacob.sherkow@nyls.edu"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"This dataset contains PDFs of CRISPR patent licenses, and press releases containing patent license information, originating from Emmanuelle Charpentier."}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Law","Medicine, Health and Life Sciences"]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"Sherkow, Jacob"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2017-01-11"}]}},"files":[{"label":"Charpentier to CRISPR Therapeutics (Assignment) License, SEC.pdf","restricted":false,"version":1,"datasetVersionId":97096,"dataFile":{"id":2970155,"persistentId":"doi:10.7910/DVN/I2OKAG/705BSK","pidURL":"https://doi.org/10.7910/DVN/I2OKAG/705BSK","filename":"Charpentier to CRISPR Therapeutics (Assignment) License, SEC.pdf","contentType":"application/pdf","filesize":228933,"storageIdentifier":"s3://dvn-cloud:15990776358-516dcad7b6ea","rootDataFileId":-1,"md5":"c93cdc84f6665f92d1e369e1bf1dba58","checksum":{"type":"MD5","value":"c93cdc84f6665f92d1e369e1bf1dba58"}}},{"label":"Charpentier to CRISPR Therapeutics License, SEC.pdf","restricted":false,"version":1,"datasetVersionId":97096,"dataFile":{"id":2970156,"persistentId":"doi:10.7910/DVN/I2OKAG/CSRP4U","pidURL":"https://doi.org/10.7910/DVN/I2OKAG/CSRP4U","filename":"Charpentier to CRISPR Therapeutics License, SEC.pdf","contentType":"application/pdf","filesize":297858,"storageIdentifier":"s3://dvn-cloud:159907769b5-fd9c034ee511","rootDataFileId":-1,"md5":"159e326b937839bbce31223a3510716d","checksum":{"type":"MD5","value":"159e326b937839bbce31223a3510716d"}}},{"label":"Charpentier to ERS Genomics Press Release, ERS Genomics.pdf","restricted":false,"version":1,"datasetVersionId":97096,"dataFile":{"id":2970157,"persistentId":"doi:10.7910/DVN/I2OKAG/DJNDKW","pidURL":"https://doi.org/10.7910/DVN/I2OKAG/DJNDKW","filename":"Charpentier to ERS Genomics Press Release, ERS Genomics.pdf","contentType":"application/pdf","filesize":69256,"storageIdentifier":"s3://dvn-cloud:15990777083-9dfb34f230f1","rootDataFileId":-1,"md5":"0cf3cc47c5d30f34f10075dac2f1d3ea","checksum":{"type":"MD5","value":"0cf3cc47c5d30f34f10075dac2f1d3ea"}}}]}}}